Reviewed profile

food and beverage brand · public preview

Elvanse

Retail brand

Public category
Retail brand
Brand tier
mainstream brand
Headquarters
Japan
Is this your company?Claim Elvanse to get found by buyers, add products and certifications, correct your details, and be eligible when Talio’s AI recommends suppliers.Let our AI make the introductionGet a warm, researched intro to Elvanse — no cold outreach.
Report a changeLog in for full recordLast reviewed 2 Jun 2026 · public preview data

Overview

What Elvanse covers.

Elvanse is a prescription medication containing lisdexamfetamine dimesylate, indicated for the treatment of attention deficit hyperactivity disorder (ADHD). Originally developed by Shire plc, the product is now marketed by Takeda Pharmaceutical Company following its acquisition of Shire. It is designed as a long-acting prodrug stimulant for use in children, adolescents, and adults.

  • Positioned as a mainstream brand.
  • Headquartered in Japan.

FAQ

Questions this page answers.

What does Elvanse do?

Elvanse is a food and beverage brand based in Japan, tracked in Talio's food and beverage intelligence platform.

Is this the full Talio record?

No. This page is a public preview; proprietary metrics and workflow features remain inside authenticated Talio.

Own this company?

Get found by buyers — and the AI that recommends suppliers.

Claim this profile to appear in buyer searches, add your products and certifications, correct outdated details, and stay eligible when Talio's AI recommends suppliers.

Claiming grants reviewed submission rights only — not direct editing, suppression, or ownership of Talio-derived intelligence. Verification required.

Claim this pageLog in for full recordReport a change

Public preview data only · proprietary metrics remain in authenticated Talio.